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As a result of recent advances in diagnostic technology developed to 
screen for transfusion-transmissible diseases (TTDs), the inactivation 
of pathogens and improvement in good manufacturing practice, the 
risk of acquiring a TTD is extremely low. In South Africa (SA), 
there have been one documented HIV and two hepatitis B virus 
window period infections since the introduction of individual 
donation screening by nucleic acid amplification testing in October 
2005 (C Ingram, South African National Blood Service, personal 
communication, 2015).
However, blood transfusions still carry infectious risks, even 
though these are very slight, as well as other well-documented hazards. 
Consequently there has been an increased focus on appropriate blood 
management, with the publication of clinical trials carried out to 
establish evidence-based guidelines for the use of blood products. 
The publication of the TRICC (Transfusion Requirements in Critical 
Care) trial in 1999 showed that a restrictive approach to the use of 
red cell concentrates (RCCs) with a low haemoglobin (Hb) trigger of 
<8 g/dL had no harmful clinical effects and clinical outcomes were 
similar to those in patients treated with a more liberal transfusion 
regimen with the transfusion trigger set at 10 g/dL.[1] These findings 
have been supported by other studies focusing on high-risk patients 
undergoing hip surgery.[2]
Numerous clinical audits of blood utilisation measured against 
clinical guidelines have been published over the past decade. These 
audits serve as a tool to identify areas of practice that can be 
improved and therefore form part of quality improvement initiatives 
that may be used to enhance patient outcomes, improve safety and 
minimise costs. Elective surgical procedures are the most common 
target of transfusion audits, because they have the advantage of 
providing well-defined patient groups. One of the earliest and 
most comprehensive blood utilisation audits was the Sanguis 
project, which collected data from 43 teaching hospitals in Central 
and Western Europe. This study selected the following elective 
procedures, as they were frequently performed and often involved 
a request for blood products: right and left hemicolectomy (COLE) 
for colonic cancer, coronary artery bypass graft (CABG), unilateral 
total hip replacement (THR), abdominal aorta aneurysmectomy 
(AAA), laparoscopic cholecystectomy (CHOLE), and transurethral 
prostatectomy (TURP). The results indicated an extremely wide 
range of transfusion rates, prescribed doses and types of blood 
products used within the same patient category.[3,4] Furthermore, 
recent publications have continued to show this trend.[5-7]
Very few studies of blood utilisation practice have been conducted 
in SA.[8-10] Blood is a valuable and scarce resource, especially in a 
middle-income developing country, and there is therefore a need 
for transfusion audits to achieve optimal practice. In addition, there 
have been no audits examining the blood ordering practice for THR 
in SA. To fill this gap, a study of the utilisation of RCCs as well as 
blood ordering practices in elective THR was carried out by means 
of a retrospective clinical audit at two tertiary referral hospitals in the 
Western Cape Province.
Methods
Patient population and ethics
The study population consisted of consecutive patients each of 
whom had undergone elective THR surgery between 1 January and 
31 December 2013. The folders were examined consecutively to avoid 
selection bias. Patients were excluded from the study if they had been 
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admitted with a fracture to the hip due to 
trauma. The hospitals were encoded green 
(HG) and yellow (HY) to ensure anonymity, 
as per agreement with their management.
Ethics approval was obtained from the 
Cape Peninsula University of Technology 
Ethics Committee (Ref. no. CPUT/HW- 
REC2013/H38). Once approved, permission 
was obtained from the management of the 
respective hospitals.
Data collection and statistical 
analysis
A data collection form was devised as a tool 
to record the informa tion required for the 
audit. This included information relating to 
age, gender, clinical observations, indications 
for surgery, pre- and postoperative Hb 
values, comorbidities, length of hospital stay 
and transfusion history.
Data from individual data collection 
sheets were uploaded onto the IBM SPSS 
version 22 statistical package (IBM, USA) 
for analysis. From this, frequency tables, 
contingency tables and descriptive analysis 
for numerical variables using means, 
standard deviations (SDs) and standard 
errors were deduced. Summary statistics 
were given as means and SDs, and average 
values were presented as means or medians 
where deemed appropriate.
Performance indicators included the 
num ber of patients transfused per hospital 
as well as the number of units transfused 
per hospital. The χ2 test was used to identify 
significant differences between two or more 
groups pertaining to categorical variables or 
to test for a significant association between 
two categorical variables. Student’s t-test was 
used to compare the difference of a numeri-
cal variable between two groups (e.g. mean 
female Hb v. mean male Hb), and p-values 
were given to test the null hypothesis. A 
p-value of <0.05 was considered significant 
and would therefore reject the null hypoth-
esis.
Results
Study population
Two hundred and seven consecutive patients 
admitted for elective THR at two tertiary 
referral hospitals in the Western Cape 
between 1  January and 31 December 2013 
were studied. Eighty-seven patients were 
excluded owing to incomplete data, recent 
hip trauma or underlying malignant disease, 
with the remaining 120 patients (Table  1) 
equally divided between the two hospitals.
Transfusion rates
Fig. 1 compares the transfusion rates between 
the two hospitals. Thirty-one (25.8%) of all 
patients were transfused with RCCs, either 
intraoperatively or within 24 hours post-
operatively. Of the 31 transfused patients, 
6/60 (10.0%) were at HG and the remaining 
Table 1. Demographics and baseline characteristics
All patients Males Females
Total, N 120 48 72
Age (years), mean 64.2 61.0 66.0
Procedure, n
Primary unilateral THR 97 42 55
Revision THR 16 4 12
Primary bilateral THR 7 2 5
Indication for THR, n
Osteoarthritis 86 31 55
Rheumatoid arthritis 3 0 3
Trauma (>12 months) 5 2 3
Osteonecrosis 7 6 1
Childhood hip disease 1 1 0
Other* 12 6 6
Data unavailable 6 2 4
Comorbidities, n 91 31 60
HT 45 11 34
Diabetes 1 1 0
Diabetes + HT 10 4 6
HT + other diseases† 20 8 12
TB 2 1 1
Cardiac 4 3 1
Other‡ 9 3 6
HT = hypertension; TB = tuberculosis.
*Ankylosing spondylitis, scoliosis, painful hip.
†Cancer (in remission), asthma, TB, hypercholesterolaemia, Parkinson’s disease.
‡Myasthenia gravis, Parkinson’s disease, ulcerative colitis, chronic pulmonary disease, epilepsy, diverticulitis, Paget’s disease.
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Fig. 1. Transfusion rates.
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25/60 (41.7%) at HY. Two to three units was 
the average dose (mean 2.7). The difference 
between the two hospitals was significant 
(χ2=15.701, p<0.001). Female patients had 
a significantly higher transfusion rate than 
males (χ2=5.285, p<0.05), and although 
patients with comorbidities were more likely 
to receive blood, this did not reach statistical 
significance.
Haemoglobin values
Fig. 2 summarises the pre- and post-
surgery Hb values for all patients and 
is further broken down into those who 
were transfused v. those who received no 
RCCs. On average, the postoperative Hb 
was 2.7  g/dL lower than the preoperative 
Hb in all patients. The transfused patients 
had significantly lower mean Hb values 
than those who were not transfused (pre-
surgery Hb: t=4.821, p<0.001; post-surgery 
Hb: t=5.225, p<0.001).
Fig. 3 compares the mean preoperative 
and postoperative Hb levels in transfused 
patients at each hospital. Postoperatively, the 
mean Hb value of the transfused patients 
was 8.1 g/dL at HG and 9.3 g/dL at HY. 
Three of the 6 transfused patients at HG 
(50.0%) had Hb values >8 g/dL, whereas at 
HY 17 of the 25 transfused patients (68.0%) 
had postoperative Hb values >8 g/dL.
Gender
It is well established that there is a difference 
between the Hb values of males and females, 
and this is reflected in Fig. 4. The mean 
pre operative Hb for males and females was 
within the normal reference range for the 
Western Cape (National Health Laboratory 
Service). Despite this, the transfusion rate 
was significantly higher in female patients 
(p<0.05).
Patient age
There was no significant difference in the 
mean ages of the patients receiving blood at 
the two institutions (t=1.485, p>0.05).
The majority of patients undergoing 
THR were aged >60 years; however, the 
transfusion rate increased significantly with 
increasing age. The mean age of those who 
did not receive a transfusion was 62.16 (SD 
11.75) years, while the mean age of those 
who were transfused was 70.03 (SD 10.01) 
years (t=3.33, p<0.005).
Length of hospital stay (LOS)
The majority of patients were discharged 
within 6 - 10 days. No patient discharged 
by day 5 was transfused; in contrast, those 
receiving transfusions remained in hospital 
for a significantly longer period. In addition, 
LOS differed significantly between the two 
hospitals (mean p<0.001).
Comorbidities
As shown in Fig. 1, the transfusion rate for 
all patients with co morbidities was higher 
than in those without comorbidities, but this 
did not reach statistical significance.
Blood bank ordering analysis
Both hospitals used the group and screen 
(G&S) as the default order (n=54 at HG, 
n=48 at HY). Not unexpectedly, given the 
higher transfusion rate, HY had a larger 
number converted to a full cross-match, and 
the number of full cross-matches ordered 
preoperatively was three- to four-fold greater 
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than at HG. HG requested full cross-matches 
for 10 patients, of whom 6 were transfused 
with 11 units of RCCs, and an average of 
two units per patient was transfused. At HY, 
blood was cross-matched for 30 patients, of 
whom 25 were transfused with 73 units of 
RCCs, averaging three units per patient.
Discussion
Variation in transfusion rates for THR has 
been well documented, but is not confined 
to this operation. Other major elective 
surgical operations such as CABG, total 
knee replacement and COLE show similar 
variations,[3,11,12] but these do not appear to be 
the result of patient mix, surgical technique 
or anaesthetic practices. A national audit 
of THR in the UK documented a 1 - 100% 
variation.[5] Studies in Europe revealed a 
similar variation.[6,7] In the Sanguis study,[3] 
a number of patients also received albumin, 
artificial colloids, plasma and platelets.
Although the variation in blood 
utilisation practice is not as wide, our study 
has demonstrated a significant difference in 
the rate of transfusion of RCCs between the 
two tertiary referral hospitals. A consistent 
2 - 3 g/dL drop in Hb values postoperatively 
was docu mented in the studies mentioned 
above, and our study showed a similar mean 
decrease in postoperative Hb values of 2.7 g/
dL. This suggests that the average intra- and 
postoperative blood loss is fairly consistent 
and that variable blood loss from centre 
to centre is unlikely to be the cause of the 
variation.
In a systematic review published in 2011, 
Barr et al.[13] found that two factors consistently 
influenced the use of RCCs in orthopaedic sur-
gery, namely preoperative Hb and age. Other 
factors were increased surgical complexity (e.g. 
revision THR), low body weight, co morbidities 
and female gender.[13] In our study, the trans-
fused patients had signifi cantly lower mean 
preoperative and postoperative Hb values 
(Fig.  2). Extrapolating from Fig. 2, the ‘trig-
ger’ Hb value for transfusion at HG is 8.1  g/
dL, whereas at HY this appears to be higher at 
9.3 g/dL. Three of the 6 patients (50.0%) trans-
fused at HG had Hb values >8.0 g/dL, while at 
HY 17 (68.0%) of the 25 transfused patients 
had Hb values >8.0 g/dL.
In common with other studies, female 
gender had a significant association with 
the likelihood of transfusion. The mean pre-
operative Hb was within the normal NHLS 
reference range for both females and males, 
however, so the reason for the higher trans-
fusion rate in females is unclear.
The mean age of patients in most 
published studies of THR ranged from 63 
to 70 years. The mean age of the patients 
in our study is comparable, and there was 
no significant difference between HG and 
HY. However, the mean age of patients 
who received blood was 70 years, which is 
significantly greater than that of patients 
who received no blood (p<0.005).
Patients with comorbidities had a higher 
transfusion rate than those without, but 
this did not reach statistical significance 
(p>0.05). This may simply reflect the smaller 
number of patients studied compared with 
other reports, where the numbers were far 
greater and comorbidities influenced the 
likelihood of transfusion.
Although Barr et al.[13] did not identify LOS 
as a factor influencing the transfusion rate, 
our study revealed that an increased LOS was 
associated with an increased likelihood of 
transfusion. At both HG and HY, significantly 
more patients who were transfused had a 
hospital stay of >6 days, and all untransfused 
patients had an LOS of <5 days. This asso-
ciation could, however, reflect the clinical 
condition of the patients and the presence 
of comorbidities that were also present in 
patients receiving blood transfusions.
A G&S was the majority order of choice. 
This is appropriate given the overall 
transfusion rate and is in line with local 
clinical guidelines. If the blood bank is on 
the hospital premises, an argument could be 
made to dispense with the G&S since blood 
can be ordered and delivered rapidly from an 
on-site blood bank.
Study limitations
This was an observational retrospective 
study and as such has inherent weaknesses. 
Nevertheless, it has highlighted the need for 
clinical audits in units with regular blood 
product use to benchmark blood manage-
ment practice. Concurrent or prospective 
audits are preferable, although they are more 
difficult to conduct.
Conclusions
The findings of this audit have led to the 
conclusion and recommendation that all 
centres should have a policy for blood man-
agement that should include the following:
• A guideline ‘trigger’ Hb value of 8.0 g/dL is 
recommended because studies have shown 
that a restrictive transfusion policy is safe 
in otherwise stable isovolaemic patients, 
and guidelines[14,15] have endorsed this.This 
is a guideline, however, and must be used 
together with clinical evaluation.
• Transfusion rates must be monitored 
and reviewed regularly. Although it is 
difficult to provide a benchmark, given 
the wide variation documented, Barr et 
al.[13] reported that the average transfusion 
rate in patients undergoing THR or total 
knee arthroplasty was 26%. There are, 
however, a number of centres reporting a 
transfusion rate of <20%,[13] so it would not 
be unreasonable to have this as a target.
• This study also noted that many patients 
were anaemic pre operatively, in which 
case the cause of the anaemia should be 
identified and it should be treated if the 
cause is treatable (e.g. iron deficiency).[16,17]
• A G&S is recommended as the pre-
operative blood order.
In summary, this study demonstrated a 
significant difference in the transfusion rates 
between the two hospitals. Regular follow-
up audits of blood utilisation should be 
conducted to compare current practice with 
local or international standards. This would 
ensure that blood wastage and unnecessary 
expenditure are kept to a minimum. Further-
more, blood donations would be optimally 
utilised and blood bank requests would be 
appropriate and essential.
60
50
40
30
20
10
0
Pa
tie
nt
s,
 n
Mean postoperative Hb
Mean preoperative Hb
31 - 45 46 - 60 61 - 75 >75
Age group (years)
Fig. 5. Transfusion rates per age group.
RESEARCH
828       August 2016, Vol. 106, No. 8
The authors would like to thank Dr Corrie Uys from the Cape Peninsula 
University of Technology for performing the statistical analysis.
References
1. Hebert PC, Wells G, Blajchman MA, et al., with the Transfusion Requirements in Critical Care 
Investigators for the Canadian Critical Care Trials Group. A multicentre randomized controlled 
clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340(6):409-417. 
DOI:10.1056/NEJM.19990211
2. Carson J, Terrin M, Noveck H, et al. Liberal or restrictive transfusion in high risk patients after hip 
surgery. N Engl J Med 2011;365(26):2453-2462. DOI:10.1056/NEJM?
3. Sanguis Study Group. Group use of blood products for elective surgery in 43 European hospitals 
Transfus Med 1994;4(4):251-266. DOI:10.1111/j.1365-3148.1994.tboo262.x
4. McClelland DBL. Red cell transfusion for elective surgery: A suitable case for treatment. Transfus Med 
1994;4(4):247-249. DOI:10.1111/1365-3148.1994.tboo201.x
5. Boralessa B, Goldhill DR, Tucker K, et al. National comparative audit of blood use in elective 
primary unilateral total hip replacement surgery. Ann R Coll Surg Engl 2009;91(7):599-605. 
DOI:10.1308/003588409X432464
6. Jans O, Kehlet H, Hussain Z, Johansson PI. Transfusion practice in hip arthroplasty. Vox Sang 
2011;100(4):374-380. DOI:10.1111/j.1423-0410.2010.01428.x
7. Rosencher N, Kerkkamp HEM, Macheras G, et al. Orthopaedic Surgery Transfusion Haemoglobin 
European Overview (OSTHEO) Study: Blood management in elective knee and hip arthroplasty in 
Europe. Transfusion 2003;43(4):459-469. DOI:10.1046/j.1537-2995.00348.x
8. Rund RL, Bird AR, James MFM. Blood usage in elective surgery – a 3-month audit at Groote Schuur 
Hospital, Cape Town. S Afr Med J 1992;81(4):415-418.
9.  Bidmos A, Nel T. The usage of red cell products at Kimberley Hospital Complex: A retrospective study. 
Afr J Haematol Oncol 2011;2(2):195-196.
10. Harrison MC, Pillay S, Joolay Y, et al. Resource implications of adopting a restrictive neonatal blood 
transfusion policy. S Afr Med J 2013;103(12):916-917. DOI:10.7196/SAMJ.6858
11. Bennet-Guerrero E, Zhao Y, O’Brien SM, et al. Variation in use of blood transfusion in coronary artery 
bypass surgery. JAMA 2010;304(14):1568-1575. DOI:10.1001/jama.2010.1046
12. Gombotz H, Rehak PH, Shander A, Hoffman A. Blood use in elective surgery: The Austrian benchmark 
study. Transfusion 2007;47(8):1468-1480. DOI:10.1111/j.1537-2995.2007.01286.x
13. Barr PJ, Donnelly M, Cardwell C, et al. Drivers of transfusion decision making and quality of 
the evidence in orthopaedic surgery: A systematic review of the literature. Transfus Med Rev 
2011;25(4):304-316. DOI:10.1016/j.tmrv.2011.04.003
14. Carson J, Grossman B, Kleinman S, et al. Red blood cell transfusion: A clinical practice guideline from 
the AABB. Ann Intern Med 2012;157(1):49-58. DOI:10.7326/0003-4819-157-1-201206190-00429
15. Ingram C, Bellairs G, Bird AR, eds. Clinical Guidelines for the Use of Blood Products in South Africa. 
5th ed. WP Blood Transfusion Service and SANBS, 2014. http://www.sanbs.org.za/PDFDocuments/
services/Clinical%20Guidelines/Clinical_Guigelines_5th-Edition2014.pdf (accessed 11 July 2016).
16. Spahn DR. Anemia and patient blood management in hip and knee surgery: A systematic review of the 
literature. Anesthesiology 2010;113(2):482-495. DOI:10.1097/ALN.0b013e3181e08e97
17. Shander A, van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 
2012;109(1):55-68. DOI:10.1093/bja/aes139
Accepted 31 January 2016.
